Waters Corporation (WAT) Net Profit Margin: 11.91%
Is Waters Corporation’s net profit margin high or low?
Waters Corporation's net profit margin of 11.91% is 47% below its 5-year average of 22.39%, near the low end of its 5-year range (11.91%–24.87%).
As of Thursday, June 11, 2026. 43.10% below its 12-month average of 20.93%.
WAT Net Profit Margin Chart
WAT Average Net Profit Margin Chart
WAT Current vs Average Net Profit Margin Chart
WAT Net Profit Margin Metrics
NET PROFIT MARGIN
11.91%
NET PROFIT MARGIN AVG TTM
20.93%
NET PROFIT MARGIN AVG 3Y
21.85%
NET PROFIT MARGIN AVG 5Y
22.39%
NET PROFIT MARGIN AVG 10Y
21.03%
NET PROFIT MARGIN AVG 15Y
21.77%
NET PROFIT MARGIN AVG 20Y
21.11%
CURRENT VS TTM AVG
-43.10%
CURRENT VS 3Y AVG
-45.49%
CURRENT VS 5Y AVG
-46.79%
CURRENT VS 10Y AVG
-43.38%
CURRENT VS 15Y AVG
-45.30%
CURRENT VS 20Y AVG
-43.59%
WAT Competitors' Net Profit Margin
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Waters Corporation (WAT) | $23.21B | 11.91% | 20.93% | 21.85% | 22.39% |
| Mettler-Toledo International Inc. (MTD) | $22.82B | 21.40% | 21.94% | 21.74% | 21.20% |
| BioNTech SE (BNTX) | $22.39B | -44.73% | -31.89% | 3.77% | 12.08% |
| Veeva Systems Inc. (VEEV) | $26.31B | 28.37% | 27.22% | 24.83% | 24.72% |
| Moderna, Inc. (MRNA) | $18.71B | -143.55% | -128.24% | -70.25% | -50.87% |
| DexCom, Inc. (DXCM) | $28.92B | 19.31% | 16.12% | 14.73% | 15.57% |
| Biogen Inc. (BIIB) | $28.94B | 13.92% | 15.03% | 17.95% | 19.29% |
| Hologic, Inc. (HOLX) | $16.97B | 13.18% | 16.70% | 17.87% | 22.37% |
| IQVIA Holdings Inc. (IQV) | $30.08B | 8.33% | 8.63% | 8.47% | 7.22% |
| Medline Inc. (MDLN) | $30.90B | 3.31% | 4.39% | 2.42% | 2.42% |
Margin Comparison
Operating Margin
17.1%
Net Profit Margin
11.9%
Waters Corporation Net Profit Margin Formula & Definition
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Waters Corporation Net Profit Margin FAQ
- What is the net profit margin for Waters Corporation (WAT)?
- The net profit margin for WAT stock is 11.91%.
- Is Waters Corporation's net profit margin high or low?
- Waters Corporation's net profit margin of 11.91% is 47% below its 5-year average of 22.39%, near the low end of its 5-year range (11.91%–24.87%).
- What is the TTM average net profit margin for Waters Corporation (WAT)?
- The TTM average net profit margin for WAT stock is 20.93%.
- What is the 3Y average net profit margin for Waters Corporation (WAT)?
- The 3Y average net profit margin for WAT stock is 21.85%.
- What is the 5Y average net profit margin for Waters Corporation (WAT)?
- The 5Y average net profit margin for WAT stock is 22.39%.
- What is the 10Y average net profit margin for Waters Corporation (WAT)?
- The 10Y average net profit margin for WAT stock is 21.03%.
- What is the 15Y average net profit margin for Waters Corporation (WAT)?
- The 15Y average net profit margin for WAT stock is 21.77%.
- What is the 20Y average net profit margin for Waters Corporation (WAT)?
- The 20Y average net profit margin for WAT stock is 21.11%.
Waters Corporation Net Profit Margin History
| DATE | NET PROFIT MARGIN |
|---|---|
| 2025-12-31 | 20.30% |
| 2024-12-31 | 21.56% |
| 2023-12-31 | 21.72% |
| 2022-12-31 | 23.81% |
| 2021-12-31 | 24.87% |
| 2020-12-31 | 22.05% |
| 2019-12-31 | 24.61% |
| 2018-12-31 | 24.54% |
| 2017-12-31 | 0.88% |
| 2016-12-31 | 24.06% |
| 2015-12-31 | 22.97% |
| 2014-12-31 | 21.70% |
| 2013-12-31 | 23.63% |
| 2012-12-31 | 25.03% |
| 2011-12-31 | 23.39% |
| 2010-12-31 | 23.23% |
| 2009-12-31 | 21.57% |
| 2008-12-31 | 20.47% |
| 2007-12-31 | 18.20% |
| 2006-12-31 | 17.36% |
| 2005-12-31 | 17.44% |
| 2004-12-31 | 20.28% |
| 2003-12-31 | 17.83% |
| 2002-12-31 | 16.60% |
| 2001-12-31 | 13.33% |
| 2000-12-31 | 18.28% |
| 1999-12-31 | 17.36% |
| 1998-12-31 | 12.02% |
| 1997-12-31 | -1.78% |
| 1996-12-31 | -0.61% |
Related Metrics
About Waters Corporation
Waters Corporation is a global leader in specialized measurement, delivering analytical solutions across Asia, the Americas, and Europe. The company operates through two main divisions: Waters and TA. Under its Waters segment, it engineers, manufactures, sells, and provides support for high and ultra-performance liquid chromatography and mass spectrometry (MS) systems. This includes essential consumables like chromatography columns and comprehensive post-warranty service plans. The TA segment focuses on designing, producing, selling, and servicing instruments for thermal analysis, rheometry, and calorimetry. Additionally, Waters develops and supplies sophisticated software that integrates with both its own instruments and those from other manufacturers. The company's advanced MS technology plays a crucial role in various applications, such as drug discovery and development (including clinical trial assessments), analyzing proteins involved in disease processes, ensuring nutritional safety, and conducting environmental testing. Its thermal analysis, rheometry, and calorimetry instruments are vital for assessing the suitability and stability of a wide range of materials, including fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids. These instruments support diverse sectors like industrial manufacturing, consumer goods, healthcare products, and life science research. Waters' extensive client base spans the life sciences, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental sectors, where its products are instrumental in research and development, quality assurance, and general laboratory operations. Established in 1958, Waters Corporation is headquartered in Milford, Massachusetts.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Udit Batra